Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Cormatrix Cardiovascular Inc. has one pending office action in Medical Devices & Mechanical Engineering. The matter is assigned to one examiner and one art unit, indicating that the current prosecution activity is concentrated within a single examination channel. GANESAN, SUBA is the busiest examiner, with one pending matter associated with the portfolio.
For counsel, the concentrated assignment makes examiner-specific review particularly relevant. The record does not show distribution across multiple examiners or art units, so prosecution planning can focus on the requirements and examination practices reflected in this single matter. The pending action is the principal immediate prosecution issue identified by the available profile data.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GANESAN, SUBA | 1 | 73.8% | +13.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18436364 | PROSTHETIC VENOUS VALVES | GANESAN, SUBA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18436364 | PROSTHETIC VENOUS VALVES | GANESAN, SUBA | — |
| Art Unit | Apps |
|---|---|
| 3774 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18436364 | PROSTHETIC VENOUS VALVES | GANESAN, SUBA | 3774 | §101 | Non-Final OA | — | Pending | Feb 08, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCormatrix Cardiovascular Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Suba Ganesan has the most, with 1 of Cormatrix Cardiovascular Inc.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
